Summary by Moomoo AI
On September 30, 2024, Deep Track Capital, LP, along with Deep Track Biotechnology Master Fund, Ltd., and David Kroin, filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, indicating a shared voting and dispositive power over 10,953,937 shares of Invivyd, Inc. This represents a 9.17% stake in the company's common stock. The filing was made under Rule 13d-1(c) of the Securities Exchange Act of 1934, which is used by persons not seeking to control or influence the company but who hold more than 5% of a class of securities. The shares in question are based on 119,442,635 common stock outstanding as of August 1, 2024, according to Invivyd's Form 10-Q filed on August 14, 2024. The filing also includes a certification by David Kroin, stating that the shares were not acquired for the purpose of changing or influencing the control of Invivyd, Inc. and were not held in connection with any transaction having that purpose or effect.
